Details for Patent: 5,880,136
Summary for Patent: 5,880,136
| Title: | Sulfonamide fibrinogen receptor antagonists |
| Abstract: | A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation. |
| Inventor(s): | Mark E. Duggan, Melissa S. Egbertson, Wasyl Halczenko, George D. Hartman, William L. Laswell |
| Assignee: | Medicure International Inc , Eisai Corp of North America |
| Application Number: | US09/130,334 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,880,136
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,880,136
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0478363 | ⤷ Start Trial | SPC/GB99/042 | United Kingdom | ⤷ Start Trial |
| European Patent Office | 0478363 | ⤷ Start Trial | C990040 | Netherlands | ⤷ Start Trial |
| European Patent Office | 0478363 | ⤷ Start Trial | 2000C/002 | Belgium | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
